PPT-CIPN: Considerations for Drug Development
Pamela Horn MD Clinical Reviewer DAAAP Outline Patient Perspective from PFDD Public Meeting Drug Approval Standards Approved Therapies Possible CIPN Indications
Download Presentation
"CIPN: Considerations for Drug Development" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.